Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):e127–e134. doi: 10.1097/QAI.0000000000000664

Table 1.

Baseline characteristics of the 369 participants enrolled in the MIHNIS study

Characteristic Control Communities (n=216) Intervention Community (n=153) p-value*
Female sex, n (%) 139 64% 97 63% 0.85

Age (yrs), mean (sd) 40 13 39 10 0.40

Monthly household income (USD), mean (SD) 45 49 56 78 0.09

Household size, mean (SD) 5.7 3.0 5.8 3.1 0.76

Level of education completed, n (%) 0.36
 None 8 4% 12 8%
 Primary 140 65% 91 59%
 Secondary 56 26% 42 27%
 Post-secondary 12 6% 8 5%

Marital Status, n (%) 0.11
 Single/Never married 10 5% 3 2%
 Separated/Divorced 9 4% 15 10%
 Widowed 61 28% 39 25%
 Married 136 63% 96 63%

Walking distance to health center, n (%) <0.0001
 <30 min 28 13% 75 49%
 30–60 min 80 37% 46 30%
 >1 hour 108 50% 32 21%

Baseline stigma score (17-pt scale), mean(sd) 6.6 3.4 6.9 3.5 0.38

Baseline HIV knowledge scale (18-pt scale), mean(sd) 14.8 2.3 14.9 2.0 0.42

Time since ART initiation (yrs), mean(SD) 2.7 1.8 2.8 1.9 0.50

Baseline CD4 count (cells/mm3), mean(SD) 372 195 415 209 0.05

Baseline WHO stage 0.89
 Stage I/II 103 49% 74 51%
 Stage III 76 36% 52 36%
 Stage IV 31 15% 19 13%

Microclinic participation, n (%) 4 2% 113 74%
Group VCT participation, n (%) 2 50% 97 86%
*

univariate logistic regression of continuousor categorical predictors against study arm

larger value indicates greater perceived stigma

larger value indicates increased HIV-related knowledge